117 related articles for article (PubMed ID: 18075836)
1. Retinol and retinoic acid increase MMP-2 activity by different pathways in cultured Sertoli cells.
Dalmolin RJ; Zanotto-Filho A; De Oliveira RB; Duarte RF; Pasquali MA; Moreira JC
Free Radic Res; 2007 Dec; 41(12):1338-47. PubMed ID: 18075836
[TBL] [Abstract][Full Text] [Related]
2. Retinol and retinoic acid modulate catalase activity in Sertoli cells by distinct and gene expression-independent mechanisms.
Pasquali MA; Gelain DP; Zanotto-Filho A; de Souza LF; de Oliveira RB; Klamt F; Moreira JC
Toxicol In Vitro; 2008 Aug; 22(5):1177-83. PubMed ID: 18440196
[TBL] [Abstract][Full Text] [Related]
3. Retinol increases catalase activity and protein content by a reactive species-dependent mechanism in Sertoli cells.
Gelain DP; de Bittencourt Pasquali MA; Zanotto-Filho A; de Souza LF; de Oliveira RB; Klamt F; Moreira JC
Chem Biol Interact; 2008 Jul; 174(1):38-43. PubMed ID: 18533141
[TBL] [Abstract][Full Text] [Related]
4. Retinol up-regulates the receptor for advanced glycation endproducts (RAGE) by increasing intracellular reactive species.
Gelain DP; de Bittencourt Pasquali MA; Caregnato FF; Zanotto-Filho A; Moreira JC
Toxicol In Vitro; 2008 Aug; 22(5):1123-7. PubMed ID: 18396385
[TBL] [Abstract][Full Text] [Related]
5. Retinol induces the ERK1/2-dependent phosphorylation of CREB through a pathway involving the generation of reactive oxygen species in cultured Sertoli cells.
Gelain DP; Cammarota M; Zanotto-Filho A; de Oliveira RB; Dal-Pizzol F; Izquierdo I; Bevilaqua LR; Moreira JC
Cell Signal; 2006 Oct; 18(10):1685-94. PubMed ID: 16510265
[TBL] [Abstract][Full Text] [Related]
6. Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels.
Park EY; Wilder ET; Lane MA
Nutr Cancer; 2007; 57(1):66-77. PubMed ID: 17516864
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induces apoptosis by a non-classical mechanism of ERK1/2 activation.
Zanotto-Filho A; Cammarota M; Gelain DP; Oliveira RB; Delgado-Cañedo A; Dalmolin RJ; Pasquali MA; Moreira JC
Toxicol In Vitro; 2008 Aug; 22(5):1205-12. PubMed ID: 18474417
[TBL] [Abstract][Full Text] [Related]
8. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of retinol and retinoic acid on cell proliferation: a role for reactive species and redox-dependent mechanisms in retinol supplementation.
Zanotto-Filho A; Schröder R; Moreira JC
Free Radic Res; 2008 Sep; 42(9):778-88. PubMed ID: 18785048
[TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured Sertoli cells.
Zanotto-Filho A; Schröder R; Moreira JC
Free Radic Res; 2008 Jun; 42(6):593-601. PubMed ID: 18569017
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
Itatsu K; Sasaki M; Harada K; Yamaguchi J; Ikeda H; Sato Y; Ohta T; Sato H; Nagino M; Nimura Y; Nakanuma Y
Liver Int; 2009 Feb; 29(2):291-8. PubMed ID: 18710428
[TBL] [Abstract][Full Text] [Related]
13. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
Manna P; Sinha M; Sil PC
Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin regulates Sertoli cell expression of transferrin and interleukins.
Yamaguchi K; Ishikawa T; Kondo Y; Fujisawa M
Mol Cell Endocrinol; 2008 Feb; 283(1-2):68-75. PubMed ID: 18248879
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic lecithin: retinol acyltransferase activity by retinoic acid.
Matsuura T; Ross AC
Arch Biochem Biophys; 1993 Mar; 301(2):221-7. PubMed ID: 8460936
[TBL] [Abstract][Full Text] [Related]
16. Retinol, at concentrations greater than the physiological limit, induces oxidative stress and apoptosis in human dermal fibroblasts.
Gimeno A; Zaragozá R; Vivó-Sesé I; Viña JR; Miralles VJ
Exp Dermatol; 2004 Jan; 13(1):45-54. PubMed ID: 15009115
[TBL] [Abstract][Full Text] [Related]
17. Modulatory role of lipoic acid on lipopolysaccharide-induced oxidative stress in adult rat Sertoli cells in vitro.
Aly HA; Lightfoot DA; El-Shemy HA
Chem Biol Interact; 2009 Dec; 182(2-3):112-8. PubMed ID: 19699728
[TBL] [Abstract][Full Text] [Related]
18. The effect of retinol and retinoic acids on lipoxygenase activity.
Goldreich D; Grossman S; Sofer Y; Breitbart E; Sklan D
Int J Vitam Nutr Res; 1997; 67(1):4-9. PubMed ID: 9119612
[TBL] [Abstract][Full Text] [Related]
19. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
[TBL] [Abstract][Full Text] [Related]
20. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
